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Abstract
Small Estimated Placental Volume Predicts Low Birthweight
Kimberly M. Murdaugh, John W. Emerson, Katherine H. Campbell, France Galerneau,
Amber M. Anders, Yoonjoo K. Lee, Pritha Subramanyam, Andrea Roberts, Harvey J.
Kliman. Department of Obstetrics, Gynecology, and Reproductive Services, Yale University,
School of Medicine, New Haven, CT.

The objective of the study was to validate Estimated Placental Volume (EPV) in a
population of patients at Yale-New Haven Hospital (YNHH) across a range of gestational
ages, and to evaluate the association between small EPV and low birthweight (BW). From
2009 to 2011, 366 patients at YNHH received ultrasound scans between 11+0 to 38+6
weeks gestational age (GA) to measure placental dimensions from 2009 to 2011. EPVs were
calculated using a previously validated convex-concave shell equation. An EPV vs GA best
fit curve was generated. The relationship between EPV and BW was analyzed. Subgroup
analyses were performed to evaluate differences between study participants who delivered at
YNHH, and those who did not. Analysis of EPV versus gestational age revealed a parabolic
curve with the following best fit equation: EPV = (0.372 GA – 0.00364GA2)3. One hundred
seventy four of the 366 women who underwent EPV measurement delivered at Yale-New
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Haven Hospital (YNHH) and had their infants’ BWs recorded. The remaining patients
delivered at outlying hospitals, where BWs were not available to the investigators. However,
parabolic EPV GA curves generated from these two patient populations were
superimposable. YNHH patients with an EPV in the bottom 50th percentile had 2.42 times
the odds of having a newborn with a BW in the bottom 50th percentile (95% CI 1.27 – 4.68).
Microscopic evaluation of two placentas corresponding to the smallest EPV outliers revealed
significant placental pathology. We conclude that placental volume increases throughout
gestation and follows a predictable parabolic curve. Very low EPV measurements are
associated with low BWs. Therefore, EPV may be useful as a screen to identify women who
are carrying fetuses who are at risk for intrauterine growth restriction.
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“
[placenta] is the bundle of life.”
-Ancient Egyptian text (3000 B.C.)

1
Introduction
Role of the Placenta in Pregnancy
It is well established that the placenta plays several vital roles during pregnancy, and is
essential for nutrient and oxygen transfer between mother and fetus.[1] Placentas that are
small for gestational age are associated with intrauterine growth restriction (IUGR),
intrauterine fetal demise (IUFD), and other complications.[2-7] The relationship between
small placental size and fetal complications was explored by Wolf et al in 1989[8]. The
authors performed a longitudinal study on 18 pregnant patients between 16 and 20 weeks
gestation, and estimated placental volume and fetal weight by ultrasound at regular intervals.
In normal fetuses, a sigmoid relationship was observed between placental volume and
gestational age, as well as fetal growth and gestational age. Eleven patients experienced
adverse fetal outcomes, including fetal distress requiring Cesarean-section, fetal death, or
birthweight below the 10th percentile. For all of these patients, the placental vs gestational
age growth curve demonstrated restricted placental growth. The authors concluded that
placental growth restriction preceded fetal growth restriction and adverse events.
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Physiologically, these small placentas were unable to meet the metabolic needs of the
growing fetuses. [8]
Just as small placentas are linked to adverse fetal outcomes, Eskild et al showed that a
placenta that are significantly larger than average are also associated with poor transition to
extrauterine life.[9] The authors performed a population study of 522,360 singleton
pregnancies in Norway between 1998-2008. They calculated the ratio of placental weight to
birthweight, and divided this data set into quartiles. Higher placental weights, as well as high
placental weight:birthweight ratios were associated with Apgar scores ≤7. When they
compared the highest and lowest placental weight: birthweight quartiles, they found that
infants with a higher ratio had 1.65 times the odds of having an Apgar score ≤7 (95% CI
1.57–1.74). Eskild et al hypothesized that in these cases, chronic intrauterine hypoxia causes
compensatory increases in placental size, which in turn contributes to lower Apgar scores.[9]
Shehata et al further examined the relationship between the placental weight:birthweight
ratio and fetal outcomes.[10] In a retrospective study, they divided their data set into three
groups: high, normal, and low placental weight:birthweight ratios. In addition to reproducing
the Eskild et al result that high ratios were associated with Apgar scores <7 [9], they also
found that high ratios were associated with breech presentation, need for Cesarean-section,
and NICU admission. Conversely, low placental weight: birthweight ratios were associated
with lower rates of these adverse outcomes.[10]
Of note, with the exception of placental volume, many placental parameters do not
impact placental weight or birthweight. Haeussner et al examined whether various physical
characteristics of the placenta – diameter, thickness, roundness, shape, and cord insertion –
were associated with placental weight. After analyzing these parameters in 418 placentas
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from uncomplicated pregnancies, they concluded that variations in shape did not impact
placental weight or birthweight.[11]

Ultrasound Methods for Assessing Placental Volume

3D Ultrasound
Given the association between extremes in placental size and fetal complications,
physicians developed methods to use ultrasound to measure placental volume. Wolf et al.
first described 3D placental ultrasound in 1989.[12] They imaged n parallel slices of the
placenta separated by a given distance (dn), and measured the corresponding area of each
slice (An). They also recorded the angle of incidence of the ultrasound beam onto the slices
(q). Using these parameters, they used the following rectangular model to calculate the
placental volume (PV):

PV = {1/3(A1) + 1/2 (d1)(A1) + ½ (d1 + d2)(A2)) +…+ 1/2 (dn-2 + dn-1)(An-1)
+ 1/2 (dn-1)(An) + 1/3(An)}sin(q)

Their equation could be applied to placentas up to 26 weeks gestation. It was challenging to
assess the volume of posterior placentas after 26 weeks because the relatively large fetus cast
an acoustic shadow on its placenta.[12]
As an alternative to the multiplanar method, several authors described a method for
using Virtual Organ Computer-aided Analysis (VOCAL) and eXtended Imaging VOCAL
(XI VOCAL) to measure placental volume.[13-15] Nowak et al compared multiplanar and
VOCAL methods for measuring the placentas of fetuses between 7 and 10 weeks gestation.
They found a strong relationship between placental volume and gestational age, and reported
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that there was a strong agreement between multiplanar and VOCAL methods of placental
ultrasound.[14] Despite the strengths of 3D ultrasound, there are several complications
associated with this modality: many 3D ultrasound machines require specialized software for
image processing, 3D reconstruction of the placenta, and calculation of the placental
volume.

2D Ultrasound
In an effort to overcome the challenges associated with 3D ultrasound, Costantini et al
studied whether they could use 2D ultrasound to predict low placental weight in utero.[16]
In 95 patients with high-risk pregnancies between 19 and 23 weeks gestation, they measured
the maximum placental dimension. High-risk pregnancies were defined as having significant
IUGR or preeclampsia. Using a cut-off of 10 cm for maximal dimension, they found that
small placentas were not associated with a placental weight less than the 10th percentile. Since
the false-positive rate was 25.5%, the authors concluded that placental length was not an
effective screening tool for low placental weight. [16]
Although placental length was not a good predictor of placental weight in high-risk
populations, in 2012, McGinty et al aimed to determine whether measuring both placental
length and thickness could be used to predict whether a pregnancy would result in an SGA
or AGA infant among low-risk patients.[17] They measured placental length and thickness
in 520 low-risk pregnancies, and correlated these with birthweight percentiles upon delivery.
Neither the placental thickness, nor the ratio between placental thickness and length, were
associated with birthweight. However, placental length less than the 10th percentile was
associated with 2.8 times the odds of an SGA infant (95% CI 1.1 – 6.9).[17] In an analysis of
1909 pregnancies, Schwartz et al also found that placental thickness and diameter were much
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smaller in pregnancies resulting in SGA infants. Therefore, both groups of authors
recommended placental ultrasound as a means to evaluate risk of SGA infants.[18]

Comparison of 2D and 3D Ultrasound
While 2D ultrasound requires fewer computational and physical resources than 2D
ultrasound, according to Riccabona et al, using 2D images to estimate volumes of irregular
and ellipsoid structures is associated with an error of 10-20%.[19] In light of this, they
evaluated whether 3D ultrasound could more accurately measure volumes than 2D
ultrasound. Using a 3D ultrasound scanner that utilized the multiplanar method, they
measured the volume of balloon phantoms of various sizes and shapes by placing the probe
on the phantoms directly, and then by submerging them in a bath of water and cornstarch
(to mimic the echogenicity of tissue). They demonstrated that 3D ultrasound had similar
accuracy to 2D ultrasound when measuring elliptical objects, but was markedly more
accurately when measuring irregularly-shaped objects. Since the placenta is irregularly
shaped, 3D ultrasound was a promising tool for measuring placental volume.[19]
Higgins et al compared the accuracy of 2D and 3D ultrasound during third trimester
pregnancies in predicting placental volume (measured after delivery).[20] They used the
ellipse and shell technique for assessing placental volume with 2D ultrasound, and the
multiplanar approach for assessing placental volume with 3D ultrasound. They found good
agreement between the two methods, and concluded that they both correlated well with
placental volume ex vivo (with 3D ultrasound being more accurate).[20]
Several mathematical models that have been shown to improve the accuracy of 2D
ultrasound. In 2015, Kozinszky et al compared the 3D VOCAL to two separate 2D
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ultrasound models for calculating volume: the shell of a spherical sector model and the spherical
cap model. In this group of 346 uncomplicated pregnancies, they found a correlation of 0.86
between the 2D method and VOCAL. Additionally, the two methods demonstrated good
agreement with the measured placental volume ex vivo.[21]

Low Placental Volume Estimates Associated with Low Birthweight
Several studies explored the relationship between placental volume (estimated from
imaging in utero) and low birthweight. Some of the earliest of these studies utilized 2D
ultrasound. In 2000, Kinare et al examined the relationship between mid-pregnancy placental
volume and birthweight in a population of rural Indian women.[22] They used 2D
ultrasound to measure placental volume, and recorded data about the patients’ height,
weight, and biochemical parameters. Of note, most of the women were of short stature and
had low BMI (average height 1.52 m; average BMI 18 kg/m2). They found that low prepregnancy maternal weight was associated with low placental volume. Furthermore, small
placental volume was independently associated with low birthweight.[22] In 2001, Thame et
al reevaluated whether 2D ultrasound estimates of placental volume could predict the size of
the infant at birth.[1] They assessed placental volume, biparietal diameter, femoral length,
and head and abdominal circumference, at 14, 17, and 20 weeks gestation. At the time of
delivery, neonate weight and length, as well as length, chest, head, and abdominal
circumference were assessed. The authors also measured placental weight at birth. Compared
to fetal anthropometry, placental volume was the most predictive of birthweight at the three
points of gestation.[1]
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Studies using 3D ultrasound also showed a positive relationship between in utero
placental volume estimates and birthweight. In 2011, Antsaklis et al performed a study on
156 patients to evaluate the relationship between placental, gestational sac, and embryo
volumes (measured by 3D ultrasound) and birthweight at delivery.[23] They concluded that
placental, gestational sac, and embryo volumes increased as the gestation progressed. Fetal
volume had the strongest association with birthweight (r2 = 0.24, p = 0.003). Although
placental volume had a weakly positive association with birthweight (r2 = 0.16, p = 0.047),
the authors concluded that placental volume was still weakly predictive of birthweight.[23]
The relationship between small placental volume and low birthweight was also observed
during MRI studies of placenta. Derwig et al obtained placental MRI images during the
second trimester of 83 singleton pregnancies.[24] Of these patients, 46 were considered
small for gestational age (SGA), defined as having a birthweight below the 10th percentile.
Placental volumes were significantly lower in pregnancies leading to SGA infants than in
pregnancies leading to average for gestational age (AGA) infants. The authors also used
transvaginal ultrasound to image the uterine arteries, and assessed the pulsatility index (PI).
The PI provides an estimate of placental blood flow; higher PI values represent higher
impedance to blood flow, and therefore reduced flow. In addition to being associated with
SGA infants, low placental volumes were associated with high PI. Therefore, the authors
concluded that low uterine perfusion likely contributed small placental volumes (likely due to
failure of the spiral arteries to convert to low-resistance blood vessels).[24]
Pomorski et al used 3D power Doppler to further explore these relationships between
low placental volume, reduced placental perfusion, and birthweight.[25] In a study of 120
patients (20 IUGR, 100 normal) during the second and third trimesters, they used 3D power
Doppler to measure three vascular indices: vascularization index (VI), flow index (FI), and
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vascularization flow index (VFI). The VI, which represents the fraction of organ perfusion,
is obtained by calculating the ratio of color voxels to total voxels on the Doppler image.
The FI represents the flow velocity, and is obtained by averaging the colors of the Doppler
image. The VFI represents the total perfusion and blood flow, and is calculated by averaging
the voxels with and without color. The authors found that the placentas in IUGR
pregnancies were, on average, 92.42 cm3 smaller than those in normal pregnancies, and had
lower values for VI, FI, and VFI.[25] Similarly, during a study of 388 women, Odibo et al
found that low values for three vascular indices in the first trimester are associated with
preeclampsia.[26]

Current Practice
Despite the association between small placental size and adverse fetal outcomes,
evaluation of placental area or volume is not part of current prenatal care guidelines.[2, 27] A
number of technical challenges could explain why measuring placental volume is not
common practice: historically, methods for measuring placental volume relied on MRI or 3D
ultrasound, and were time-consuming, expensive, and required extensive training.[4, 28-30]
In an effort to promote placental evaluation during routine prenatal examinations,
Abramowicz et al described a systematic approach for placental ultrasound.[28] They
recommended measuring placental size in two dimensions, and measuring thickness if the
placenta seems abnormally small. In addition to measuring placental size, they suggested
imaging placental location, implantation, anatomy, and morphology.[28] However, despite
these recommendations and advances in techniques to measure placental volume, it is still
not commonly performed in prenatal evaluation.
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Estimated Placental Volume (EPV) Technique
Given the potential importance of measuring placental volumes on gestational outcomes,
a simpler approach was needed to encourage physicians to incorporate this screening tool
into their practice. In 2010, Azpurua et al described a technique that utilizes 2-dimensional
(2D) and mathematical modeling to estimate placental volume.[27] Unlike previous
techniques, their estimated placental volume (EPV) technique could be performed quickly at
the bedside by a healthcare provider with minimal training. This approach for estimating
placental volume correlated well with actual placental weights.
In 2013, Arleo et al validated this method and developed normative EPV growth curves
based on data from 423 patients at Weill Cornell Medical Center.[2] In a small subset of four
patients, they demonstrated that EPV may be a useful tool for detecting abnormally small
placentas. Aye et al compared EPV to a semi-automated method for measuring placental
volume.[31] This technique, which was developed by Grady et al,[32] utilizes a random walk
algorithm to rapidly assess the volume of placentas of varying shapes. They found that the
semi-automated method was more accurate than EPV at estimating placental between 11
and 13 weeks gestation, when placentas are more heterogeneous in shape. Nonetheless, EPV
was still an accurate measure of assessing placental volume, and is less expensive than the
technique presented by Aye et al.[32]
Our Study: EPV in the YNHH Population
In our study, we aimed to validate EPV compared to birthweight in a large cohort at
Yale, and to evaluate the odds that small EPV is associated with low BW. Our goal was to
contribute to the growing EPV literature, in an effort to promote adoption of simple
screening tool with potential clinical benefit.
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“…neither is ther eoccasion for returning and refining this blood [of the fetus] in the lungs of the mother,
because that office is sufficiently performed in the placenta until the foetus is delivered, when its own lungs are
put to sufficient use”
-William Smellie, 1752

2
Statement of Purpose
Specific Aims


To evaluate the relationship between EPV and BW in a population of patients
presenting for obstetrical care at YNHH



To examine placental pathology of select patients whose infants had low EPVs or
adverse fetal outcomes

Hypothesis


Small EPV is associated with a statistically significant increased risk of low BW.
Therefore, EPV can be used as a screening tool to detect low BW.



The placentas associated with low EPV or adverse fetal outcomes demonstrate
significant pathology.
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“The [umbilical] vessels join on the uterus like the roots of plants and through them the embryo receives its
nourishment.”
-Aristotle, On the Generation of Animals (340 B.C.)

3
Methods
Placental Ultrasound
This study was approved by the Yale University School of Medicine Human
Investigation Committee (protocol number 0905005157). Informed written consent was
obtained for each patient. Using a method for calculating EPV previously developed and
validated [2, 27], 419 studies were performed on 366 patients (by trained ultrasonographers
or physicians) to measure placental width, height and thickness dimensions. For each
participant, an ultrasound image of the placenta with overlaid measurements was printed and
saved for future quality control review. The patients’ estimated gestational age (GA) at the
time of the scan was recorded. For this analysis we only evaluated the first EPV collected
from each patient, resulting in a set of 366 EPV data points. For participants who delivered
their baby at YNHH, the infant’s BW (BW) was recorded at the time of delivery. For the
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remaining patients who did not deliver at YNHH, BW data was not available to the
investigators.
Inclusion/Exclusion Criteria
Inclusion criteria were as follows: any pregnant woman between 8 and 42 weeks
gestation; singleton gestation; and 18 years old or greater. Exclusion criteria included:
rupture of membranes, intramural fibroid, placenta previa; and women in active labor.
Data Analysis
Using R version 3.3.2 (The R Foundation for Statistical Computing Platform) statistical
software, an EPV vs GA best fit curve was generated. Subgroup analyses were performed to
elucidate differences between the populations of participants who delivered at YNHH, and
those who did not. In particular, the gestational age at which women presented for their first
ultrasound scan was compared. Additionally, individual EPV vs GA curves were generated
and compared for these two groups. For the 174 patients who we had BW data for, plots
were generated comparing the standard residuals of EPV and BW. Small EPVs and small
BWs (defined based on the plots of standard residuals of EPV and BW) were defined as a
positive screening test and positive condition, respectively. R was also used to calculate the
odds ratio that a small EPV is associated with a small BW. (Statistical regressions were
performed by author JE; statistical analysis and interpretation performed by authors KMM,
JE, HJK.)
Placental Pathology
Placental pathology samples from select cases were formalin-fixed and paraffin
embedded, stained with hematoxylin and eosin, and examined with a Nikon Eclipse 80i
microscope.(Placental pathology samples were collected, stained, and examined by author
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HJK. Interpretation and discussion of placental pathologies were performed by KMM and
HJK).
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“Just as the fingers of the hand are interwoven…so the fleshy [placental] villi of these little sponges are
interwoven.”
- Leonardo da Vinci (15th century)

4
Results
Our first objective was to explore the relationship between EPV and GA within the
Yale data, and compare this to a previously published set of EPV versus GA data from Weill
Cornell Medicine.[2] Both datasets demonstrated a parabolic relationship between EPV and
GA (Figure 1). The previous data were best fit with the following equation: EPV = (0.384
GA – 0.00366GA2)3, while our data were best fit with the following equation: EPV = (0.372
GA – 0.00364GA2)3. The virtual identity of the coefficients suggested that the intrinsic
biology of the placentas were the same in both groups, that is, the placentas grew at similar
rates in both populations as the gestations progressed.
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Fig. 1. Estimated Placental Volume (cc) versus Gestational Age (weeks) curves for the entire
Yale data set (solid black curve), published Cornell coefficients (solid green curve), and the
Yale data set with available BW (black dashed curve). The Yale raw data are plotted for the
points that did have BWs recorded (circles) and did not (triangles).

We next explored whether there were systematic differences between the patients
that delivered at YNHH and those that did not. If a patient delivered at YNHH, the BW was
recorded. Unfortunately we did not have BW data for patients who had EPV scans
performed at YNHH, but who delivered at outlying hospitals. However, the two data sets

16

were very similar, both in terms of GA at EPV accrual (Fig. 2A), and the best fit of EPV vs
BW (Fig. 2B).

Fig. 2. Comparison of patients who delivered at YNHH and patients who delivered outside
YNHH. (A) Gestational Age at time of EPV performance plotted for patients who delivered
at YNHH (black) and outside of YNHH (red). The solid horizontal lines represent the
medians for each group. (B) EPV versus GA for the entire Yale data set (black solid curve),
patients who delivered at YNHH (black circles, fitted with black dashed curve), and outside
of YNHH (red circles, fitted with red dashed curve).

We compared EPV values to BWs by plotting the standardized residuals of each
parameter (Fig. 3). The majority of the data fell within ± 2.57 standard deviations for EPV
and BW (red dots, corresponding to the 0.5 to 99.5th percentiles). Eight data points were
well beyond 2.57 standard deviations (black dots). The r2 value for the all the EPV vs BW
data equaled 0.063 (p<0.001), black regression line, Fig. 3. When we eliminated the 8 outliers
the r2 equaled 0.054 (p=0.003), red regression line, Fig. 3. Since these regression lines
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virtually overlapped, this suggested that the placentas corresponding to these extreme values
of EPV and BW had the same intrinsic characteristics as the non-outlier points in the data
set, and were therefore not biologically implausible.
Although dividing the data into four quadrants gives the data equal weight across the
data set, one is able to perform a 2x2 analysis to evaluate the potential clinical utility of the
EPV as a screening tool. The result of this analysis yielded an OR 2.42, 95% CI 1.27 – 4.68.
This associates a small EPV with a small BW or conversely a large EPV with a large BW
(Figure 3). Patients with an EPV in the bottom 50th percentile had 2.42 times the odds of
having a newborn with a BW in the bottom 50th percentile.
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Fig. 3. Standardized residuals for EPV versus BW. The red points represent data with
standardized residuals less than or equal to ±2.57, while the black points represent residuals
greater than ±2.57 (less than the 0.5th percentile or greater than the 99.5th percentile). The red
regression line represents the r2 for the red-point data, while the black line represents the r2
for all the data points. The outlier black data point (A) corresponds to Fig. 4A, while the
black data point (B) corresponds to Fig. 4B.

Finally we analyzed the medical records of the 2 most extreme outliers with the
lowest EPVs and BWs to determine if they could inform us about the pathogenesis of these
very small placentas. For the first case (Figure 3, lower left corner black dot), the mother was
a smoker who had previously delivered an infant with IUGR. In this study, her baby had an
EPV of 103 cm3 at 30+3 weeks (more than 4 standard deviations below the mean). A male
was delivered at 38+1 weeks with BW of 1,580 g (more than 3 standard deviations below the
mean). Apgar scores at 1 and 5 minutes were 9 and 9, respectively. Microscopic analysis of
the placenta revealed lymphocytic infiltrate of the chorionic villi, consistent with chorionic
villitis (Fig. 4A). For the second case (Figure 3, lower left mid-quadrant black dot), the
mother had a history of Crigler-Najjar syndrome (status-post liver transplant), and alcohol
use disorder (in early remission during her pregnancy for this study). Her baby had an EPV
of 269 cm3 at 32+4 weeks (more than 2 standard deviations below the mean). A female was
born preterm at 34+1 weeks with a BW of 1,010 grams (almost 3 standard deviations below
the mean). Apgar scores at 1 and 5 minutes were 4 and 6, respectively. Evaluation of the
placenta revealed failure of conversion of the spiral arteries (Fig. 4B), which is associated
with pre-eclampsia and IUGR. [33]
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Fig. 4. Placental pathology of the two extreme EPV outlier cases highlighted in Fig. 3. (A)
Multiple chorionic villi are agglutinated and enmeshed in fibrin and maternal T-cells,
characteristic of chronic villitis (CV). (B) Junction of placenta and maternal decidua
revealing normal maternal venules (V), but unconverted maternal spiral arterioles (A), a
common finding in decreased maternal perfusion of the placenta. Hematoxylin and eosin
staining.
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“Surely, the placenta will deserve…increasing attention, for it is the essential structural basis…between
mother and child.”
-James Dixon Boyd, Cambell oration to the Ulster Medical Society (1959)

5
Discussion
This research study involved performing 2D ultrasound and EPV measurements on
patients who presented to YNHH for prenatal care. The EPV vs GA data were plotted and
fit with a validated mathematical model previously described by authors at Weill Cornell
Medical.[2] Our EPV data were very similar to those collected at Cornell, suggesting that
placental growth kinetics are an intrinsic characteristic of the placenta and not significantly
influenced by patient population. Outliers should raise suspicion for intrinsic problems with
the placenta (i.e. decreased maternal perfusion), or mismatch between the size of the
placenta and the fetus.
Of the 366 patients where EPV studies were performed, only 174 patients eventually
delivered at YNHH, where BW were recorded. The remaining patients delivered at an
outlying hospital, where BW data was not available to the investigators. Because we were
concerned that the YNHH delivered patients might represent a biased subgroup, we
performed subgroup analyses on these two populations. We found that in fact they were
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very similar, with almost superimposable EPV accrual GA, and EPV vs GA growth kinetics
(Fig. 2).
When we compared EPV to BW we found a modest relationship between these two
variables. An initial crude analysis by dividing the results into four quadrants of low and high
EPV compared to low and high BW resulted in an OR 2.42, 95% CI 1.27 – 4.68 associating
a low EPV with a low BW. When we used all the data in a continuous analysis, we found a
weak correlation between EPV and BW (r2 = 0.063). However, EPV was never intended to
predict BW directly. Rather, we propose that EPV be used to identify extreme outliers of
placental volume that may be associated with IUGR, IUFD, and other adverse fetal
outcomes. Analysis of the standardized residuals (Fig. 3) suggested that extremely small
EPVs are associated with extremely low BWs.
Examining the two extreme EPV outlier cases illustrated the importance of
incorporating EPV into clinical practice. Both babies demonstrated IUGR. In both cases,
there were several maternal variables that could contribute to adverse fetal outcomes (e.g.
smoking, alcohol use, history of hepatobiliary pathology). Although these variables could
potentially confound the relationship between placental size and fetal complications, it is
noteworthy that EPV was extremely small in both cases. In practice, there may be important
underlying maternal medical conditions that the mother and obstetrician might be unaware
of. In such cases, EPV could serve as a red flag to follow the mother and fetus more closely,
and to evaluate the placenta for underlying pathology.
Because EPV is so easy to perform, we recommend routine EPV measurements
whenever the fetus is examined by ultrasound. A small EPV for gestational age could serve
as an alert to the obstetrician to follow the mother and baby more closely.[2, 27] There are
differences in the clinical utility between an early EPV versus a late gestational EPV
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measurement. Prior to the GA of viability there is little direct action that can be proposed in
the face of a very small EPV. In those cases following the patient and fetus, possibly with
increased frequency, may be the only option. However, as the patient approaches GAs with
increased probability of survival, the decision for more intense fetal evaluation, and possible
delivery, becomes more advantageous.
This study has several limitations. First, having all of the BW data would have
increased the number of patients analyzed and therefore would have increased the
generalizability of the study. Second, as our patients were solicited in our routine prenatal
care clinics, we had a low frequency of adverse pregnancy outcomes in the patients studied.
Future studies could focus on high-risk patients where adverse outcomes are more common.
Furthermore, EPV efficacy could be validated during labor and delivery triage to identify
high-risk patients with very small placentas who might be inappropriately discharged due to
reassuring fetal monitoring.
Unlike previous methods for determining placental volume,[27-30, 34] obtaining 2D
ultrasound images of the placenta and calculating EPV is fast and requires minimal cost and
training. It is a robust method with demonstrated validity across different populations. As
such, it has the potential for clinical utility in a variety of settings.
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